FDA to discuss easing restrictions on peptides despite safety concerns
By
Jessica Glenza
9d ago
Source
The GuardianFDA to discuss easing restrictions on peptides despite safety concernstheguardian.comCommittee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy Advisers to the Food and Drug Administration (FDA) will soon hold a meeting about whether to ease restrictions on access to some research peptides, a group of drugs with a zealous following and thin evidence to support them. If restrictions are eased, US compounding pharmacies would be able to produce and fill prescriptions for Americans – a change that would effectively legalize a thriving gray market. Continue reading...
You might also wanna read
The US is hooked on unregulated peptides. But are they effective, or even safe?
Live Science·1d ago
FDA PCAC Hearing July 2026: What's at Stake for Compounded Peptide Access
This article covers the upcoming July 23-24, 2026 FDA Pharmacy Compounding Advisory Committee (PCAC) hearing on peptides nominated for the 5
pepmed.org·3d ago
RFK Jr. pushes peptide deregulation; FDA scientists cite lack of safety evidence
Health Secretary Robert F. Kennedy Jr. is pushing to deregulate several peptides, making them more accessible through compounding pharmacies
nbcnews.to·4d ago
FDA Panel on Peptide Drugs Includes Experts with Financial Ties to Unproven Chemical Industry
The FDA has announced participants for an upcoming meeting to reconsider the safety and effectiveness of controversial peptide drugs. The pa
medpagetoday.com·5d ago
FDA Scientists Find Insufficient Evidence for Peptides, Undercutting RFK Jr.'s Push for Expanded Access
FDA career scientists have determined there is insufficient evidence to support the safety and efficacy of peptides being considered for pro
medpagetoday.com·3d ago
Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure
This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont
vectorculture.substack.com·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.